[Treatment of hepatitis C in intravenous drug users].
Filoche
Bernard
B
Service d'Hépatogastroentérologie, GHICL, Hôpital Saint-Philibert, Lomme.
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D001803:Blood Transfusion; D005500:Follow-Up Studies; D005838:Genotype; D015658:HIV Infections / Q000150:complications; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D001523:Mental Disorders / Q000150:complications / Q000209:etiology; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000628:therapy; D013997:Time Factors
D000998:Antiviral Agents; D007372:Interferons